← back to search

Andrew Whitelaw

National Health Laboratory Service · ZA
Area of research
Infectious Diseases · Molecular Medicine
Research interest
Research interests include Tuberculosis Research and Epidemiology, Antibiotic Resistance in Bacteria, Neonatal and Maternal Infections, and Antibiotic Use and Resistance.
h-index
59
citations
13,156
works
349
NIH funding
primary concept
Medicine
email

Recent publications

Distribution of capsule and O types in Klebsiella pneumoniae causing neonatal sepsis in Africa and South Asia: A meta-analysis of genome-predicted serotype prevalence to inform potential vaccine coverage.
2026cited by 3position: contributordoi
Contribution of nosocomial transmission to Klebsiella pneumoniae neonatal sepsis in Africa and South Asia: An observational study of infection clusters inferred from pathogen genomics and temporal data.
2026cited by 0position: contributordoi
Development of a Bloodstream Infection Surveillance Programme at a Resource-Limited South African Neonatal Unit.
2025cited by 0position: contributordoi
Reviewing the review.
2025cited by 0position: contributordoi
Prevalence of carbapenem-resistant Enterobacterales colonisation in hospitalised neonates.
2025cited by 0position: contributordoi
Ciprofloxacin resistance in <i>Klebsiella pneumoniae</i> : phenotype prediction from genotype and global distribution of resistance determinants
2025cited by 0position: contributordoi
Colonisation of hospital surfaces from low- and middle-income countries by extended spectrum β-lactamase- and carbapenemase-producing bacteria.
2024cited by 25position: contributordoi
Assessment of three antibiotic combination regimens against Gram-negative bacteria causing neonatal sepsis in low- and middle-income countries.
2024cited by 16position: contributordoi
Displacement of Hospital-Acquired, Methicillin-Resistant <i>Staphylococcus aureus</i> Clones by Heterogeneous Community Strains in Kenya over a 13-Year Period.
2024cited by 2position: contributordoi
Enhanced pathogen identification among patients with clinically suspected meningitis.
2024cited by 1position: contributordoi
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
The Lancet Infectious Diseases 2023cited by 83position: middledoi
Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study
The Lancet Infectious Diseases 2023cited by 31position: middledoi
Epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Enterobacterales in Africa: A systematic review.
2023cited by 22position: contributordoi
Colistin use in a carbapenem-resistant &lt;i&gt;Enterobacterales&lt;/i&gt; outbreak at a South African neonatal unit.
2023cited by 11position: contributordoi
Circumstances for treatment and control of invasive Enterobacterales infections in eight hospitals across sub-Saharan Africa: a cross-sectional study
Gates Open Research 2023cited by 6position: middledoi
Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study
The Lancet Global Health 2022cited by 236position: middledoi
Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study.
2022cited by 148position: contributordoi
Effect of antibiotics on the human microbiome: a systematic review.
2022cited by 53position: contributordoi
Tracing TB: Are there predictors for active TB disease in patients with Xpert Ultra trace results?
2022cited by 16position: contributordoi
Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital
Journal of Global Antimicrobial Resistance 2022cited by 10position: lastdoi
Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital.
2022cited by 7position: contributordoi
Implementation of a customised antimicrobial resistance laboratory scorecard in Cameroon, Ethiopia and Kenya.
2022cited by 5position: contributordoi
A five-year retrospective descriptive study on the clinical characteristics and outcomes of candidaemia at a tertiary hospital in South Africa.
2022cited by 4position: contributordoi
Corrigendum: Carriage of colistin-resistant Gram-negative bacteria in children from communities in Cape Town (Tuberculosis child multidrug-resistant preventive therapy trial sub-study).
2022cited by 0position: contributordoi
More than <i>Mycobacterium tuberculosis</i> : specific site-of-disease microbial communities, functional capacities, and their distinct clinical profiles in tuberculous lymphadenitis
2022cited by 0position: contributordoi
Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries
Nature Microbiology 2021cited by 435position: middledoi
Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries.
2021cited by 296position: contributordoi
Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS).
2021cited by 91position: contributordoi
<i>In Vitro</i> Antifungal Resistance of Candida auris Isolates from Bloodstream Infections, South Africa.
2021cited by 58position: contributordoi
A retrospective analysis of pathogen profile, antimicrobial resistance and mortality in neonatal hospital-acquired bloodstream infections from 2009-2018 at Tygerberg Hospital, South Africa.
2021cited by 31position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 17 papers (2019–2025)Angela Dramowski · Western Cape Department of Health14 papers (2020–2025)J. Anthony G. Scott · Haramaya University4 papers (2021–2023)Alexander M. Aiken · London School of Hygiene & Tropical Medicine3 papers (2021–2023)Anne von Gottberg · National Health Laboratory Service3 papers (2013–2021)Cheryl Cohen · Nevada Division of Public and Behavioral Health3 papers (2012–2021)Nelesh P. Govender · St George's, University of London2 papers (2021–2021) · 2 papers (2021–2023)Hajo Grundmann · Hospital for Sick Children2 papers (2021–2022)Susan Meiring · National Center for Communicable Diseases2 papers (2012–2013)Anneke C. Hesseling · Desmond Tutu HIV Foundation2 papers (2021–2022)Vanessa Quan · University of Cape Town2 papers (2012–2013)Emmanuel Roilides · The Royal Melbourne Hospital2 papers (2020–2024)Andrea M. Rehman · London School of Hygiene & Tropical Medicine2 papers (2021–2022) · 2 papers (2012–2013) · 2 papers (2021–2023)Julia Bielicki · University of Lausanne2 papers (2020–2024)Ebrahim Variava · Grey's Hospital2 papers (2021–2021)Marlieke E.A. de Kraker · Sint Franciscus Gasthuis2 papers (2021–2022) · 2 papers (2021–2024)